Receive The Newest Study Notifications

Talaris Therapeutics, Inc., formerly Regenerex, a privately held biotechnology company developing transformative cell therapies that have the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients, today announced full results...

HPN536 is the second TriTAC T cell engager to enter clinical development from the Harpoon pipeline Trial initiated at Sarah Cannon Research Institute in Nashville, Tenn. - a leading drug development organization Harpoon Therapeutics, Inc. (NASDAQ: HARP), a...

Enrollment Sufficient to Support the Interim Efficacy Analysis Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical...

-Surmodics, Inc. (NASDAQ: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, has resumed patient enrollment into its TRANSCEND clinical trial and is nearly 75 percent of the way to its goal of 446 randomized...

A First-in-Class Ophthalmological Recombinant Fully Human Bi-specific Fusion Protein Targeting VEGF and Complement Proteins Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality...

Clinical trials take a group of individuals and evaluate how certain treatment effects them. Data is collected and analyzed to then determine educated findings and results. It's crucial to keep patients involved during clinical trials, as otherwise, it can cause...

Aprea Therapeutics, a privately held, clinical stage biopharmaceutical company developing novel anticancer therapies targeting the tumor suppressor protein p53, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to...

 Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reports positive results for the secondary endpoints of its Phase III clinical trial evaluating the safety and efficacy of conventional...

The GAIN Trial will assess whether a new investigational medicine targeting P. gingivalis bacteria can slow or halt progression of Alzheimer’s disease Researchers seek more than 500 participants in the United States and Europe; visit www.GAINtrial.com for information...

Data to be presented today at 2019 Muscular Dystrophy Association Clinical and Scientific Conference Phase 2/3 clinical trial for suvodirsen in DMD expected to initiate in July 2019 Interim efficacy data from ongoing open-label extension study expected in H2 2019...

Circuit Clinical™ is proud to announce a unique collaboration with Roswell Park Comprehensive Cancer Center, to support the expansion of clinical trial opportunities to its outpatient oncology practices.  This collaboration marks Circuit Clinical's entry into oncology...

--Top-Line Results Show High Rates of Participant Compliance and Satisfaction and Excellent Data Integrity with Home-Based Clinical Data Capture Using Transparency Virtual TrialsTM (TVT) Platform-- --TVT Integrates Telemedicine, Mobile Health and Cloud Technologies to...

Mount Sinai Health System has launched a clinical trial of a new imaging device for detecting head and neck cancer during surgery. The device, called Otis Wide Field OCT (by Perimeter Medical Imaging), is an ultra-high-resolution imaging system that can image tumor...

Zymeworks Inc. (NYSE/TSX: ZYME), a clinical-stage biopharmaceutical company developing multifunctional therapeutics, today announced it has initiated its global multicenter Phase 2 clinical trial evaluating ZW25 in combination with standard of care chemotherapy for...

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (Nasdaq: MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that the U.S. Food and Drug Administration (FDA) has completed its review of the...

Cleveland Clinic, Mayo Clinic, and Robarts Clinical Trials will collaborate to address a critical unmet treatment need for people with Crohn’s disease The Leona M. and Harry B. Helmsley Charitable Trust has awarded $4.3 million to Cleveland Clinic, Mayo Clinic, and...

BioTime, Inc. (NYSE American and TASE: BTX), a clinical-stage biotechnology company developing new cellular therapies, announced today that updated results from a Phase I/IIa clinical study of its lead product candidate, OpRegen ®, a retinal pigment epithelium (RPE)...

Mount Sinai Health System has launched a clinical trial of a new imaging device for detecting head and neck cancer during surgery The device, called Otis Wide Field OCT (by Perimeter Medical Imaging), is an ultra-high-resolution imaging system that can image tumor...

- Oral presentation of ASPIRO results to include new data, with up to 48-weeks of follow-up for all patients in dose Cohort 1 and up to 24-weeks in the earliest patients in dose Cohort 2 - Presentation to be featured in the plenary session "Presidential Symposium...

New data include secondary endpoint analyses of clinical responder rates at Day 7, End of Treatment, and Test of Cure, and pre-specified analyses of the clinical responder rates by final diagnosis at Day 14 New MRSA data shows that the increased response previously...